Biblio
Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells. Exp Mol Med. 2023.
FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells. Redox Biol. 2020;36:101589.
. Mitochondria-centric bioenergetic characteristics in cancer stem-like cells. Arch Pharm Res. 2019.
.